What's new? Log in Free sign up

InfuSystem (INFU) News and press releases

Company Profile

News

From Benzinga Pro

Earnings Scheduled For May 4, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.

InfuSystem Reaffirms FY23 Guidance

InfuSystem is reaffirming its annual guidance for the full year 2023 with net revenue growth estimated to be in the range of 8% to 10%, or approximately $118 million to $121

InfuSystems Holdings Q1 EPS $(0.02) Misses $0.02 Estimate, Sales $30.37M Beat $28.84M Estimate

InfuSystems Holdings (AMEX:INFU) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.02 by 200 percent. This is unchanged from the same period last year. The company reported

12 Health Care Stocks Moving In Wednesday's Intraday Session

InfuSystems Holdings Q4 EPS $0.01 Misses $0.04 Estimate, Sales $28.83M Miss $30.80M Estimate

InfuSystems Holdings (AMEX:INFU) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.04 by 75 percent. This is a 50 percent decrease over earnings of $0.02 per share from the

Earnings Scheduled For March 15, 2023

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.

InfuSystems Holdings Earnings Preview

Press releases

From Benzinga Pro

InfuSystem to Present at Sidoti Micro-Cap Virtual Conference on May 11, 2023

Investor Presentation to be held at 9:15 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for

InfuSystem Reports First Quarter 2023 Financial Results

Record Net Revenues of $30.4 million Representing 13% Growth From the Prior Year InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating

InfuSystem to Report First Quarter 2023 Financial Results on May 4, 2023

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for

InfuSystem Announces Distribution Agreement with Genadyne for Negative Pressure Wound Therapy Systems

InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers,

InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2022

Full Year 2022 vs. Full Year 2021: Record Net Revenues: $109.9 million, a 7% increase ITS Revenue: $68.9 million - DME Revenue: $41.0 million, increases of 5% and 12% Adjusted EBITDA: $20.7 million 2023 Full Year

InfuSystem to Report Fourth Quarter and Full Year 2022 Financial Results on March 15, 2023

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.